Mezzion Pharma Co.Ltd (140410) - Total Liabilities

Latest as of March 2026: ₩83.41 Billion KRW ≈ $56.53 Million USD

Based on the latest financial reports, Mezzion Pharma Co.Ltd (140410) has total liabilities worth ₩83.41 Billion KRW (≈ $56.53 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Mezzion Pharma Co.Ltd (140410) equity growth momentum to track the company's year-over-year net asset growth rate.

Mezzion Pharma Co.Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Mezzion Pharma Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See 140410 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Mezzion Pharma Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Mezzion Pharma Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Cheng Mei Materials Technology Corp TW:4960	Taiwan	NT$5.06 Billion
Shanthi Gears Limited NSE:SHANTIGEAR	India	Rs1.16 Billion
Bosch Fren Sistemleri Sanayi ve Ticaret AS IS:BFREN	Turkey	TL718.59 Million
Hangzhou Landscape Architecture Design Institute Co Ltd SHE:300649	China	CN¥402.17 Million
ALPHA KLSE:0303	Malaysia	RM58.34 Million
Bsm Chemical Co Ltd SHE:300796	China	CN¥1.50 Billion
Moso Power Supply Technology Co Ltd SHE:002660	China	CN¥776.68 Million
Stillfront Group AB (publ) ST:SF	Sweden	Skr7.04 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Mezzion Pharma Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Mezzion Pharma Co.Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.47	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	5.38	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.84	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mezzion Pharma Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mezzion Pharma Co.Ltd (2012–2025)

The table below shows the annual total liabilities of Mezzion Pharma Co.Ltd from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩80.83 Billion ≈ $54.78 Million	+189.35%
2024-12-31	₩27.94 Billion ≈ $18.93 Million	-9.02%
2023-12-31	₩30.70 Billion ≈ $20.81 Million	+10.52%
2022-12-31	₩27.78 Billion ≈ $18.83 Million	+31.41%
2021-12-31	₩21.14 Billion ≈ $14.33 Million	+12.36%
2020-12-31	₩18.82 Billion ≈ $12.75 Million	+17.28%
2019-12-31	₩16.04 Billion ≈ $10.87 Million	-9.56%
2018-12-31	₩17.74 Billion ≈ $12.02 Million	-14.99%
2017-12-31	₩20.87 Billion ≈ $14.14 Million	-51.57%
2016-12-31	₩43.09 Billion ≈ $29.20 Million	+6.35%
2015-12-31	₩40.52 Billion ≈ $27.46 Million	+921.54%
2012-12-31	₩3.97 Billion ≈ $2.69 Million	--

About Mezzion Pharma Co.Ltd

KQ:140410 Korea Pharmaceuticals

Market Cap

$341.71 Million

₩504.23 Billion KRW

Market Cap Rank

#14053 Global

#411 in Korea

Share Price

₩59000.00

Change (1 day)

+15.69%

52-Week Range

₩36450.00 - ₩172700.00

All Time High

₩172700.00